TP53 and Miyoshi myopathy: These results demonstrate that MAGE-A regulates Bim and p21Cip1 to inhibit apoptosis and promote cell cycle progression, and this activity contributes to survival, resistance to chemotherapy, and proliferation in p53 wt MM cells.